These biotech stocks all popped after their recent earnings reports. All three have outperformed 97% of stocks in the last 12 months.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual ...

Dealmaking is back with a vengeance in the pharmaceutical sector this year. According to a report by PwC, there were more than $65 billion in pharma and life sciences mergers & acquisitions in the ...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) is one of the best biotech stocks on this list. TheFly reported on June 10 that UBS increased its price target on CLDX to $45 from $38 while maintaining a Buy ...

Investing in up-and-coming stocks means having an appetite for risk, as this approach often involves chasing the latest Wall Street buzz. For instance, right now, some of the highest fliers are ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

All that has changed, and if you want to invest in growth away from AI, biotech might be where you want to be. Below, I will attempt to lay out the various macro and policy disruptions that had a ...

Biotech investors are finally getting something they haven't seen in years: a friendlier macro environment. Interest rates appear to be stabilizing, FDA activity is picking up again, and large ...

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.

Legend Biotech has frequently been at the center of takeover rumors, and the stock regularly spikes on speculation that it has received formal buyout bids. It stands out as one of the most uniquely ...